Xu Y - Search Results

1

Secretory status of monoclonal immunoglobulin is related to the outcome of patients with myeloma: a retrospective study.

Qin XQ, An G, Li ZJ, Liu LT, Xu Y, Yang LH, Ma YP, Deng SH, Sui WW, Qin Y, Feng XY, Zang MR, Yang WJ, Zhang YR, Yi SH, Wang TY, Lv R, Zou DH, Zhao YZ, Qiu LG. Qin XQ, et al. Among authors: xu y. Blood Adv. 2019 Mar 12;3(5):751-760. doi: 10.1182/bloodadvances.2018019851. Blood Adv. 2019. PMID: 30833275 Free PMC article.

2

[Analysis of the international staging system of multiple myeloma and its comparison with the DS and IFM staging system in 122 Chinese patients].

Deng SH, Xu Y, Mai YJ, Wang YF, Zhao YZ, Zou DH, Qiu LG. Deng SH, et al. Among authors: xu y. Zhonghua Xue Ye Xue Za Zhi. 2008 Apr;29(4):217-21. Zhonghua Xue Ye Xue Za Zhi. 2008. PMID: 18843972 Chinese.

3

[The efficacy of thalidomide for multiple myeloma: a clinical analysis of 102 Chinese patients].

Qi PJ, Wang YF, Xu Y, Li YN, Zou DH, Zhao YZ, Xiao ZJ, Qiu LG. Qi PJ, et al. Among authors: xu y. Zhonghua Xue Ye Xue Za Zhi. 2008 Apr;29(4):226-9. Zhonghua Xue Ye Xue Za Zhi. 2008. PMID: 18843974 Chinese.

4

[Outcome of bortezomib plus chemotherapy with or without stem cell transplantation for treatment of multiple myeloma].

Wang YF, Deng SH, Wu T, Xu Y, Zou DH, Wang Y, Zhao YZ, Qiu LG. Wang YF, et al. Among authors: xu y. Zhonghua Xue Ye Xue Za Zhi. 2008 Jun;29(6):397-400. Zhonghua Xue Ye Xue Za Zhi. 2008. PMID: 19031743 Chinese.

5

[The Clinical features of myeloma bone disease.].

Li SD, Xu Y, Wang YF, Zhao YZ, Jiang S, Qiu LG. Li SD, et al. Among authors: xu y. Zhonghua Xue Ye Xue Za Zhi. 2010 Apr;31(4):228-32. Zhonghua Xue Ye Xue Za Zhi. 2010. PMID: 20510037 Chinese.

6

[The significances of 13q14 deletion for development and prognosis of multiple myeloma].

Li Q, An G, Li CW, Xu Y, Deng SH, Liu XP, Qi JY, Wang YF, Zou DH, Zhao YZ, Qiu LG. Li Q, et al. Among authors: xu y. Zhonghua Xue Ye Xue Za Zhi. 2011 Apr;32(4):217-20. Zhonghua Xue Ye Xue Za Zhi. 2011. PMID: 21569701 Chinese.

7

Further stratification of patients with multiple myeloma by International Staging System in combination with ratio of serum free κ to λ light chains.

Xu Y, Sui W, Deng S, An G, Wang Y, Xie Z, Yao H, Zhu G, Zou D, Qi J, Hao M, Zhao Y, Wang J, Chen T, Qiu L. Xu Y, et al. Leuk Lymphoma. 2013 Jan;54(1):123-32. doi: 10.3109/10428194.2012.704033. Epub 2012 Sep 5. Leuk Lymphoma. 2013. PMID: 22712834

8

[Analysis of the efficacy and prognosis on first-line autologous hematopoietic stem cell transplantation of patients with multiple myeloma].

Zou DH, Sui WW, Yi SH, An G, Xu Y, Li ZJ, Li CW, Qi JY, Zhao YZ, Qiu LG. Zou DH, et al. Among authors: xu y. Zhonghua Xue Ye Xue Za Zhi. 2013 Apr;34(4):299-303. doi: 10.3760/cma.j.issn.0253-2727.2013.04.011. Zhonghua Xue Ye Xue Za Zhi. 2013. PMID: 23668200 Chinese.

9

[Clinical feature and efficacy of patients with multiple myeloma and renal impairment treated with bortezomib based chemotherapy].

Xu Y, An G, Deng SH, Sui WW, Feng XY, Li F, Hao M, Wang YF, Qiu LG. Xu Y, et al. Zhonghua Xue Ye Xue Za Zhi. 2013 Apr;34(4):304-8. doi: 10.3760/cma.j.issn.0253-2727.2013.04.012. Zhonghua Xue Ye Xue Za Zhi. 2013. PMID: 23668201 Chinese.

10

t(11;14) multiple myeloma: a subtype associated with distinct immunological features, immunophenotypic characteristics but divergent outcome.

An G, Xu Y, Shi L, Zou D, Deng S, Sui W, Xie Z, Hao M, Chang H, Qiu L. An G, et al. Among authors: xu y. Leuk Res. 2013 Oct;37(10):1251-7. doi: 10.1016/j.leukres.2013.06.020. Epub 2013 Aug 5. Leuk Res. 2013. PMID: 23927993

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,830 results

Search Page

Filters